Improved plasmablast response after repeated pneumococcal revaccinations following primary immunization with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia
CONCLUSION: In CLL patients, pneumococcal revaccination induced minor early plasmablast response compared to controls, but the response improved using a strategy of repeated doses with of conjugated T cell dependent pneumococcal vaccine.PMID:37061372 | DOI:10.1016/j.vaccine.2023.04.016
Source: Vaccine - Category: Allergy & Immunology Authors: Magdalena K ättström Bertil Uggla Elisabet Tina Eva Kimby Torbj örn Norén Simon Athlin Source Type: research
More News: Allergy & Immunology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Clinical Trials | Leukemia | Meningitis Vaccine | Pneomococcal Vaccine | Study | Vaccines